Osteoclasts control osteoblast chemotaxis via PDGF-BB/PDGF receptor beta signaling

Research output: Contribution to journalResearch articleContributedpeer-review

Contributors

  • Maria Arantzazu Sanchez-Fernandez - (Author)
  • Anne Gallois - (Author)
  • Thilo Riedl - (Author)
  • Pierre Jurdic - (Author)
  • Bernard Hoflack - , TUD Dresden University of Technology (Author)

Abstract

Background: Bone remodeling relies on the tightly regulated interplay between bone forming osteoblasts and bone digesting osteoclasts. Several studies have now described the molecular mechanisms by which osteoblasts control osteoclastogenesis and bone degradation. It is currently unclear whether osteoclasts can influence bone rebuilding. Methodology/Principal Findings: Using in vitro cell systems, we show here that mature osteoclasts, but not their precursors, secrete chemotactic factors recognized by both mature osteoblasts and their precursors. Several growth factors whose expression is upregulated during osteoclastogenesis were identified by DNA microarrays as candidates mediating osteoblast chemotaxis. Our subsequent functional analyses demonstrate that mature osteoclasts, whose platelet-derived growth factor bb (PDGF-bb) expression is reduced by siRNAs, exhibit a reduced capability of attracting osteoblasts. Conversely, osteoblasts whose platelet-derived growth factor receptor β (PDGFR-β) expression is reduced by siRNAs exhibit a lower capability of responding to chemotactic factors secreted by osteoclasts. Conclusions/Significance: We conclude that, in vitro mature osteoclasts control osteoblast chemotaxis via PDGF-bb/PDGFR-β signaling. This may provide one key mechanism by which osteoclasts control bone formation in vivo.

Details

Original languageEnglish
Article numbere3537
JournalPloS one
Volume3
Issue number10
Publication statusPublished - 27 Oct 2008
Peer-reviewedYes
Externally publishedYes

External IDs

PubMed 18953417

Keywords

ASJC Scopus subject areas